Shionogi Announces Licensing of Symproic® (naldemedine) to BioDelivery Sciences International Inc.
OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi Inc. (hereafter “Shionogi”) announced today that BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a…